A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
about
Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virusRibavirin monotherapy for chronic hepatitis CAntiviral therapy for recurrent liver graft infection with hepatitis C virusRibavirin plus interferon versus interferon for chronic hepatitis CChallenges of recurrent hepatitis C in the liver transplant patientDiagnosis, management, and treatment of hepatitis C: an updateHepatitis C and liver transplantationTreatment of hepatitis C infection. Review underplayed important public health issuesRecurrent hepatitis C after liver transplantation: clinical and therapeutical issues.Pre- and post-transplant treatment of hepatitis C.Treatment of hepatitis C virus infectionEffects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection.Hepatitis B and C in the liver transplant recipient: current understanding and treatment.Mechanisms of action of ribavirin in antiviral therapies.Treatment of recurrent hepatitis C.Pre-emptive treatment of recurrent hepatitis C infection.Effect of ribavirin alone or combined with silymarin on carbon tetrachloride induced hepatic damage in rats.Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.Management of hepatitis C in liver transplant recipients.SASLT practice guidelines: management of hepatitis C virus infection.Antihepatitis C virus therapy in liver transplanted patients.Outcome of liver transplantation for haemophilia.Viral hepatitis in solid organ transplantation.Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.Rimantadine for treatment of hepatitis C infection in liver transplant recipients.Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.I favor therapy for hepatitis C virus recurrence after transplantation.Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C.Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma.Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.
P2860
Q24201973-11640893-5B9D-4F34-8827-E917603DB3CBQ24240057-608D1134-81DB-4327-AEFB-B11683034019Q24240405-C0EBDD6B-9263-4BBB-B4FD-8855EBA712D1Q24240879-15876065-8B71-45D2-A2F3-2C7150251D04Q27011871-7C7FF321-4FA3-483F-9455-126166EAA6E8Q29619682-D4724671-45B2-44C4-8BB4-EB2CA55E77C3Q33686173-D7F62717-D5F0-488A-B366-87A6E7313F95Q33710546-8C6E3F16-71F8-4096-A8B1-6A9EFC1ECA80Q33888820-E1FD8177-ABC0-46E6-A1F5-43D96EA949E4Q33988139-1DC1E2C5-9396-44C7-B173-4FC65616277AQ34099424-0A5BF737-125F-4644-96A3-C1C36C576128Q34294938-4227CEBC-D838-41F6-8591-224215E9C22CQ34426421-9287B64E-995B-42AC-95DC-2DBD92BE6C97Q34521747-3B7D86DC-4F28-44AD-9F11-F9E28522F679Q34936164-2FA77D65-CFA9-488E-917A-45ACF37B1809Q34936216-6999B34A-AEE9-47D1-9D1B-4F6CE6932987Q35161778-3472B2BF-2C80-458C-9A72-23E64C850E3CQ36028318-66FCDBE1-D920-463A-91F4-62DDD5EB16C3Q36392142-2E9A9177-E16E-44D2-B9BD-990EF2FFBA2FQ37019765-A3505C4E-E58C-418F-81DF-91A1960D7431Q39887907-281A5EEA-1973-4918-9D58-D6D63D95965EQ42162860-0F936B6D-7ABE-4086-A757-31B732C4E852Q42272319-67C2058B-5A09-4193-B50C-3CEEBC6A13A5Q42984161-EA324C17-3784-490D-B9CC-1A93AF866A5DQ42991499-A63FFB48-1176-44EF-B9FB-991800A89E6BQ42993598-135102C6-A55D-4EA2-9ED5-821292703C50Q43040383-8F5F11C1-1AC9-477E-A715-DFBBACF2D79BQ43040909-54181DB6-88B6-4A30-A8A2-D604CEA18E8FQ43049477-6A88AAC9-E721-4C75-B7DF-0B75E8238132Q44211421-A97686DD-E942-4658-BE71-0443B6CEAA5BQ44243304-7B827C11-CE7D-466A-A2F1-90A43551B77BQ50584454-78A9FC41-4DE7-4411-948D-E9A9C2F9D309
P2860
A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
A randomized study comparing r ...... e after liver transplantation.
@en
A randomized study comparing r ...... e after liver transplantation.
@nl
type
label
A randomized study comparing r ...... e after liver transplantation.
@en
A randomized study comparing r ...... e after liver transplantation.
@nl
prefLabel
A randomized study comparing r ...... e after liver transplantation.
@en
A randomized study comparing r ...... e after liver transplantation.
@nl
P2093
P356
P1433
P1476
A randomized study comparing r ...... e after liver transplantation.
@en
P2093
Naoumov NV
Portmann BC
Riordan SM
Williams R
P304
P356
10.1002/HEP.510270530
P407
P577
1998-05-01T00:00:00Z